Zobrazeno 1 - 10
of 20
pro vyhledávání: '"Madhulata Kumari"'
Autor:
Madhulata, Kumari, Naidu, Subbarao
Publikováno v:
Future medicinal chemistry. 14(21)
bBackground:/bIn the recent COVID-19 pandemic, SARS-CoV-2 infection spread worldwide. The 3C-like protease (3CLpro) is a promising drug target for SARS-CoV-2.bResults:/bWe constructed a deep learning-based convolutional neural network-quantitative st
Autor:
Madhulata Kumari, Naidu Subbarao
Publikováno v:
Journal of Biomolecular Structure and Dynamics. 40:8185-8196
Current therapeutic strategies for several diseases, including Mycobacterium tuberculosis infection, have evolved from an initial single-target treatment to a multitarget one. A multitarget antitubercular drugs targeting different mycobacterial prote
Autor:
Madhulata Kumari, Naidu Subbarao
Publikováno v:
Future medicinal chemistry. 14(10)
Background: Marburg virus (MARV) is a sporadic outbreak of a zoonotic disease that causes lethal hemorrhagic fever in humans. We propose a deep learning model with resampling techniques and predict the inhibitory activity of MARV from unknown compoun
Publikováno v:
Future Medicinal Chemistry. 12:147-159
Aim: We applied genetic programming approaches to understand the impact of descriptors on inhibitory effects of serine protease inhibitors of Mycobacterium tuberculosis ( Mtb) and the discovery of new inhibitors as drug candidates. Materials & method
Autor:
Madhulata Kumari, Naidu Subbarao
Publikováno v:
Journal of Biomolecular Structure and Dynamics. 38:5062-5080
Glutamine synthetase (GS) of Mycobacterium tuberculosis (Mtb) is an essential enzyme which is involved in nitrogen metabolism and cell wall synthesis. It is involved in the inhibition of phagosome-lysosome fusion by preventing acidification. Targetin
Nature provides an infinite variety of plant species which includes number of neglected and underutilized crops that have been pushed into forgetfulness by the predominant ‘major’ cereals. Millets and pseudo-cereals belong to such category having
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::433f7031eaafe55d2518913c294b7284
https://doi.org/10.1016/b978-0-12-820089-6.00004-5
https://doi.org/10.1016/b978-0-12-820089-6.00004-5
Autor:
Aparna Agarwal, Supriya Babasaheb Aglawe, null Anuradha, Lalit Arya, Rahul Chandora, Ajay Kumar Chandra, B.S. Chethana, T.M. Dinesh, K.N. Ganapathy, K. Hariprasanna, A.K. Jain, D.C. Joshi, R.P. Joshi, S. Sanjeev Krishna, Madhulata Kumari, Nikhil Malhotra, N.G. Malleshi, R.P. Meena, A. Nagaraja, Sri Devi Nune, V. Ramya, B. Dayakar Rao, A.B. Narayana Reddy, Y.A. Nanja Reddy, Y.N. Priya Reddy, Harpreet Kaur Saini, Babita Sharma, Krishan Datt Sharma, Mamta Singh, Mohar Singh, Monika Singh, Salej Sood, L.S. Suma, Apoorv Tiwari, Vilas A. Tonapi, Manjusha Verma
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::87a261c38928fbd57736e8606d88c528
https://doi.org/10.1016/b978-0-12-820089-6.09992-4
https://doi.org/10.1016/b978-0-12-820089-6.09992-4
Multi-targeting enzyme approaches are considered to be the most significant in suppressing pathogen growth and disease control for MDR and XDR-resistant Mycobacterium tuberculosis. The multiple Mur enzymes involved in peptidoglycan biosynthesis play
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::e5f8c5ada3f8eefa2e4ac5fb07303319
Publikováno v:
Future medicinal chemistry. 12(2)